Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East Read more
SPARC licenses development and commercialisation rights of PDP-716 and SDN-037 to Visiox Pharma Read more
SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target Read more
Carlyle partners with Viyash Life Sciences to build generic pharmaceutical platform in India Read more